ABSTRACT
Objective: Trends in maternal mortality (MMR) and late maternal mortality ratios (LMMR) were estimated, in periods with and without H1N1 and COVID-19 pandemics, in Rio de Janeiro, Brazil, from 2009 to 2021.
Methods: Ecological study of temporal trends. Data was obtained from the Mortality and Live Birth Information Systems. The annual MMR and LMMR per 100,000 live births (LB) were calculated and the trends were estimated using the joinpoint regression model.
Results: In 2009, the MMR was 103.1, reaching 152.4/100,000 LB in 2021, with an annual reduction of 3.3% (95% confidence interval - 95%CI -5.5; -1.7) until 2019 and an increase of 51.2% (95%CI 23.5; 64.5) in 2020/21. Excluding the years of the COVID-19 pandemic, it was observed that an annual decline of 3.3% and, with the concomitant exclusion of the years of the H1N1 pandemic, stability. The LMMR were 8.3 (2009) and 22.2 (2021) per 100,000 LB, with an annual growth of 28.2% (95%CI 11.8; 47.8) until 2011, remaining stationary from 2011 to 2015, followed by an increase of 11.7% until 2021; with the exclusion of the final biennium, the trend is upward (3.8%) and also with the exclusion of the initial biennium, the trend became downward (7%) until 2014 and upward (8.2%) from then on.
Conclusion: There was a change in trend with the separate or joint incorporation of pandemic biennia: without pandemics, maternal mortality would be stationary, despite actions to prevent maternal deaths, and late maternal mortality, would be descending until 2014 and then ascending, crediting itself in part, to improving death investigation.
Keywords:
Time series studies; Maternal mortality; Influenza A virus, H1N1 subtype; COVID-19
RESUMO
Objetivo: Estimar as tendências das razões de mortalidade materna (RMM) e mortalidade materna tardia (RMMT), em períodos com e sem as pandemias de H1N1 e COVID-19, no estado do Rio de Janeiro, Brasil, de 2009 a 2021.
Métodos: Estudo ecológico de tendência temporal. Dados obtidos dos Sistemas de Informações sobre Mortalidade e Nascidos Vivos. Foram calculadas as RMM e RMMT anuais por 100 mil nascidos vivos (NV) e foi aplicado o modelo de regressão joinpoint para estimar a tendência.
Resultados: Em 2009, a RMM foi 103,1, alcançando, em 2021, 152,4/100.000 NV, com redução anual de 3,3% (intervalo de confiança de 95% — IC95% -5,5; -1,7) até 2019, e ascensão de 51,2% (IC95% 23,5; 64,5) em 2020/21. Excluindo-se os anos da pandemia de COVID-19, observou-se declínio anual de 3,3% e, com a concomitante exclusão dos anos da pandemia de H1N1, estabilidade. As RMMT foram 8,3 (2009) e 22,2 (2021) p/100.000 NV, com crescimento anual de 28,2% (IC95% 11,8; 47,8) até 2011, mantendo-se estacionária de 2011 a 2015, seguida de ascensão de 11,7% até 2021; com a exclusão do biênio final, a tendência é ascendente (3,8%) e, com a exclusão também do biênio inicial, a tendência passou a ser descendente (7%) até 2014 e a seguir ascendente (8,2%).
Conclusão: Houve mudança de tendência com a incorporação separada ou conjunta dos biênios pandêmicos: sem as pandemias, a mortalidade materna seria estacionária, apesar das ações de prevenção do óbito materno, e a materna tardia seria descendente até 2014 e depois ascendente, creditando-se tais tendências em parte à melhoria da investigação de óbito.
Palavras-chave:
Estudos de séries temporais; Mortalidade materna; Vírus da influenza A subtipo H1N1; COVID-19
INTRODUCTION
Globally, one woman dies every two minutes due to complications related to pregnancy or childbirth1, corresponding to a maternal mortality ratio (MMR - defined as the risk of maternal death during pregnancy or within 42 days postpartum) of 223 per 100,000 live births (LB) in 20202. In the same year, Brazil reported an MMR of 72 per 100,000 LB, approximately 16 times higher than Germany and eight times higher than Cuba, highlighting a significant potential for reduction3. Between 2000 and 2020, the average annual decrease in the global MMR was 2.1%, whereas in Latin America and the Caribbean, the trend remained stagnant3.
The H1N1 influenza pandemics in 2009 and 2010, as well as the COVID-19 (SARS-CoV-2) pandemic approximately a decade later (beginning in Brazil in 2020), affected maternal mortality rates4,5,6, although they do not fully account for the observed trends3. Due to anatomical and physiological changes in the cardiovascular, respiratory, immune, and coagulation systems during pregnancy, women are more susceptible to viral pneumonias, particularly during pandemics, which exacerbate preexisting challenges within healthcare systems6,7.
Sustained transmission of the influenza A (H1N1) virus was officially declared nationwide on July 19th, 2009. That year, nearly 60,000 cases and 2,146 deaths were reported in the country. In 2010, following the introduction of vaccination, the number of deaths declined to approximately one hundred8,9. More than 10% of total deaths caused by the H1N1 pandemic occurred among pregnant women, most of whom had no underlying health conditions10. In the first quarter of 2010, the monovalent anti-H1N1 vaccine was distributed across the country9. A decade later, by June 2020, Brazil had recorded 124 deaths among women in the pregnancy-puerperal cycle due to COVID-19, representing 12.7% of deaths among pregnant women hospitalized for severe acute respiratory syndrome (SARS)11. COVID-19 was associated with 18% and 43% of national maternal deaths in 2020 and 2021, respectively12. Complete COVID-19 immunization during pregnancy was shown to be highly protective against severe maternal morbidity and mortality in a cohort of pregnant women treated at a public general hospital in the state of Rio de Janeiro13. In both viral pandemics, women in the pregnancy-puerperal cycle were considered a high-risk group for severe maternal morbidity and mortality11,12,13. According to Vega et al.14, pandemic situations should not be considered in the analysis of historical maternal mortality trends, as they are exceptional events, comparable to major catastrophes, that function as external factors, independent of public health management, affecting populations unprepared to respond effectively14.
With advancements in life support technology, the 42-day postpartum limit traditionally used to define maternal mortality has become increasingly inadequate15. In the United States, the inclusion of information on pregnancy within the year preceding death on death certificates (DC) has contributed to improved detection of late maternal mortality (from 43 days to one year after delivery)16.
In Brazil, beyond the incorporation of pregnancy-related information into DC, the epidemiological investigation of deaths among women of childbearing age and maternal deaths, implemented since 2008, has played a key role in reducing the underreporting of maternal and late maternal deaths17,18. Between 2010 and 2019, the country experienced an upward trend in late maternal mortality, increasing from 2.2 to 5.6/100,000 LB, with an annual growth rate of 9.8% and notable regional disparities19. In the city of São Paulo (SP) and the state of Paraná, late maternal deaths accounted for 13.4 and 12.1% of total maternal deaths, respectively17. These deaths are largely preventable through timely and effective treatment, underscoring the importance of extending postpartum monitoring, particularly for women at higher risk17,18,19. Failure to address late maternal deaths contributes to fragmented care and missed opportunities for prevention20.
This study aimed to analyze trends in MMR and late maternal mortality (LMMR) during periods with and without the influenza A (H1N1) and COVID-19 pandemics in the state of Rio de Janeiro, from 2009 to 2021.
METHODS
An ecological study was conducted to analyze the temporal trends of the annual MMR and LMMR in the state of Rio de Janeiro from 2009 to 2021.
Maternal deaths are defined as those occurring during pregnancy, childbirth, or within 42 days following the end of pregnancy, regardless of the duration or location of the pregnancy, resulting from any cause related to or aggravated by the pregnancy or its management, but not from accidental or incidental causes21. The following ICD-10 codes are classified as causes of maternal death: O00.0 to O08.9, O11 to O23.9, O24.4, O26.0 to O92.7, D39.2, E23.0, F53, and M83.0 (direct obstetric causes), O10.0 to O10.9, O24.0 to O24.3, O24.9, O25, O98.0 to O99.8, A34, and B20 to B24 (indirect obstetric causes), and O95 (unspecified causes), all from Chapter XV of the ICD-10. Additionally, codes A34, B20 to B24, D39.2, E23.0, F53, and M83.0 are included when they appear outside Chapter XV but result in death during the pregnancy-puerperal cycle21.
Late maternal deaths are defined as deaths from any obstetric cause occurring more than 42 days but less than one year after the end of pregnancy, corresponding to code O96 of the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10)21.
Secondary data were obtained from the Mortality Information System (Sistemas de Informações sobre Mortalidade - SIM) and the Live Birth Information System (Sistemas de Informações sobre Nascidos Vivos - Sinasc) of the Rio de Janeiro State Health Secretariat.
The absolute and relative percentage distributions of maternal and late maternal deaths were described annually. The annual MMR and LMMR were calculated per 100,000 LB (using the ratio of maternal deaths to LB, multiplied by 100,000).
The decision to begin the temporal analysis in 2009 was based on the exclusion of a correction factor, which was only applied to MMR in the preceding period in the state of Rio de Janeiro4. The maternal mortality time series were evaluated for the entire period (2009 to 2021), as well as for periods excluding the initial biennium of the influenza A/H1N1 pandemic (2011 to 2021), the final biennium of the COVID-19 pandemic (2009 to 2019), and both pandemic biennia (2011 to 2019).
To estimate the trend, a joinpoint regression model was applied, which detects significant changes in the trend (inflection points) and fits linear segments on a logarithmic scale22,23,24. Model selection (including the number of joinpoints) was based on the weighted Bayesian Information Criterion (W-BIC). The annual percentage change (APC) was calculated to represent the direction and magnitude of the trend (significance level set at 0.05). Analyses were conducted both in the absence of autocorrelation and considering first-order serial autocorrelation. The model that best described the trend structure of the historical series was selected.
This study is part of a research project approved by the Research Ethics Committee of Universidade Federal Fluminense (Certificate of Presentation for Ethical Consideration - CAAE No. 713230230000005243; approval opinion No. 6.592.725, dated December 19, 2023).
Data availability statement
The entire dataset supporting the results of this study was published in the article itself.
RESULTS
In 2009, the number of LB in the state of Rio de Janeiro was 217,280, decreasing to 188,989 in 2021, a reduction of 13% (Table 1). It is noteworthy, however, that there was a slight increase of 8.5% in the number of LB up to 2015, followed by a decline of 25.7% thereafter (Table 1).
There were 242 maternal deaths (including late maternal deaths) at the beginning of the study period and 330 at the end, with the lowest number recorded in 2018 (174 deaths) and the highest in 2021 (Table 1). Most maternal deaths occurred within 42 days postpartum; however, there was a notable increase in the proportion of late maternal deaths (occurring between 43 days and one year postpartum), rising from 7.4% in 2009 to 18.3% in 2020. The highest value of LMMR prior to the COVID-19 pandemic was observed in 2018. The MMR showed the highest values in the initial and final biennia of the study period, ranging from 61.5 (2018) to 152.4 (2021) per 100,000 LB (Table 1).
The estimated trends, joinpoints (changes in trend), and the APC coefficients for the MMR and LMMR, with and without the inclusion of pandemic years, are summarized in Table 2. These estimates were derived considering first-order autocorrelation, as this approach provided a better fit for the trend observed in the historical series.
During the full period from 2009 to 2021, the MMR exhibited a segmented trend, with an annual decline of 3.3% until 2019 (joinpoint), followed by an annual increase of 51.2% in the final two years (COVID-19 pandemic period - Table 2). When excluding the initial two years, the trend remained downward until 2019 (APC=-2.7%), followed by an upward trend from that point onward (APC=49%). When excluding the final two years, an annual decline of 3.3% was observed, and when both pandemic biennia (initial and final) were excluded, the trend remained stable (Table 2).
For the LMMR, considering the full period, three trend changes were identified: an annual increase of 28.3% until 2011, followed by a stationary period, and, from 2015 onward, an annual increase of 11.7% (Table 2). When excluding the initial two-year period, the trend remained stationary until 2015, followed by an upward trend (APC=11.7%). Excluding the final two years, no joinpoint was observed, and the trend showed a consistent annual increase (APC=3.8%). When both the initial and final biennia were excluded, a decline of 7.0% per year was observed until 2014, followed by an annual increase of 8.2% through 2019 (Table 2).
Figures 1 (MMR) and 2 (LMMR) present the graphical representations of the observed and estimated trends in maternal and late maternal mortality from 2009 to 2021, as well as the simulated trends in the absence of pandemic periods.
Trend of maternal mortality ratio per 100,000 live births, Rio de Janeiro State, 2009 to 2021.
Trend of late maternal mortality ratio per 100,000 live births, Rio de Janeiro State, 2009 to 2021.
DISCUSSION
In the state of Rio de Janeiro, from 2009 to 2021, the MMR showed a downward trend until 2019; however, with the onset of the COVID-19 pandemic (2020-2021), the trend shifted sharply upward. The COVID-19 pandemic appears to have significantly influenced the temporal pattern of MMR. When the final two-year period is excluded, the trend reverts to a downward trajectory, even with the inclusion of the influenza A H1N1 pandemic years, and becomes stationary when both pandemic biennia are excluded. When only the initial two-year period is excluded, a declining trend is observed until the beginning of the COVID-19 pandemic, at which point the trend turns upward.
Mendonça et al.5 estimated an annual reduction of 1.3% in the MMR due to obstetric causes in the state of Rio de Janeiro between 2006 and 2018, and identified a peak in 2009, attributed to the H1N1 pandemic. This initial peak during the influenza pandemic years influenced the subsequent downward trend observed prior to the COVID-19 pandemic. Similarly, in Argentina, from 1980 to 2017, the downward trend in MMR was abruptly and temporarily interrupted in 2009 due to the H1N1 pandemic, after which the decline resumed at a faster pace25.
Excess maternal mortality during the COVID-19 pandemic years was reported in several studies, including a hospital cohort study of pregnant women in the state of Rio de Janeiro.13 The increase in maternal mortality was also observed in a national study using data from SIM7, and in a multinational cohort study involving pregnant women from 18 countries, where COVID-19 was identified as a risk factor for both maternal mortality and severe maternal morbidity (including Brazil)26. In the United States, the MMR increased by 18.4% from the year before to the first year of the COVID-19 pandemic, with the MMR rising from 20.1 per 100,000 live births in 2019 to 23.8 in 202027.
Regarding the LMMR, the temporal behavior observed in the present study differed from that of the MMR. Over the entire period, the trend was predominantly upward, although it remained stationary between 2011 and 2015. Removing the H1N1 pandemic years at the beginning of the period changed the trend’s direction, from stationary to upward from 2015 onward, with the final biennium (COVID-19) maintaining an upward trajectory. When excluding the final biennium, the trend was downward until 2014, followed by an increase. This pattern of late maternal mortality suggests that the H1N1 pandemic had a greater influence than the COVID-19 pandemic. In the absence of the influenza A/H1N1 pandemic years, the junction points (2014 and 2015) align with the Zika virus epidemic (2014-2016), which, combined with the country’s political and socioeconomic crisis, contributed to the intensification of the decline in the frequency of LB28, the denominator of LMMR, thereby favoring an increase in this indicator. However, this was not observed in the evolution of the MMR, which shares the same denominator as the LMMR. Therefore, the increase in LMMR, regardless of the presence of the H1N1 and COVID-19 pandemics, may reflect a real increase in the risk of maternal death and/or improved reporting of maternal deaths. The epidemiological investigation of deaths among women of childbearing age and maternal deaths, regulated by the Ministry of Health in 2008 (Ordinance No. 1.119 of June 5, 2008), and conducted throughout the analyzed period, may have been a significant factor contributing to the rise in the frequency of late maternal deaths, as these are more likely to be underreported compared to deaths occurring within 42 days postpartum17. A similar trend was observed in the national analysis from 2010 to 201919, although the magnitude of the annual percentage growth was lower: 3.8% in Rio de Janeiro compared to 9.8% in the country for the period from 2009 to 2019. Despite this, the LMMR in Rio de Janeiro was higher, reaching 13.4/100,000 LB in 2019, while in Brazil the figure was 5.6/100,000 LB. Between 2010 and 2019, both in Rio de Janeiro and the country as a whole, 2018 recorded the highest number of late maternal deaths19. Additionally, the negative correlation between the trends of MMR (decreasing) and LMMR (increasing), excluding the COVID-19 pandemic years, observed in our study, may reflect a shift in maternal deaths beyond 42 days postpartum due to increased survival, resulting from advances in life support technology, as seen in developed countries15,20. However, this trend was not observed when both pandemics were excluded.
The H1N1 pandemic coincided with the initiation of investigations into maternal deaths and deaths among women of childbearing age, at a time when the percentage of investigations was still low. In the country, the number of maternal deaths due to respiratory diseases quadrupled in 2009 compared to the average of previous years, and this increase was attributed to the influenza A/H1N1 pandemic29.
The excess maternal mortality observed in 2021, compared to the previous year, can be attributed to the high transmissibility of the SARS-CoV-2 Gamma variant, which was predominant during the second wave of COVID-19, as well as the delay in prioritizing pregnant and postpartum women for vaccination7,30. In five locations in Bogotá, Bolivia, 10 and 17% of maternal deaths in 2020 (total=10) and 2021 (total=23), respectively, were attributed to COVID-1931. Although the number of maternal deaths was higher in 2021 than in 2020, the proportions in Bolivia remained lower than those recorded in the state of Rio de Janeiro. At the national level, 18% of maternal deaths in 2020 and 43% in 2021 were associated with COVID-1912.
Within the study period, the year 2018 stands out due to a decrease in the MMR and an increase in the LMMR. This rise in LMMR in 2018 was also observed at the national level19. This finding suggests the possibility of misclassification related to the timing of death recorded on the DC, underscoring the importance of accurately completing the fields pertaining to the timing of death and the underlying cause.
Studies on late maternal mortality are essential to assess the magnitude of the problem and guide responses through appropriate health policies17,18,19. In the present study, based on data from SIM, the proportion of late maternal deaths (ICD-10 code O96) in the state of Rio de Janeiro increased from 7.4% in 2009 to 12.7% in 2021. Prior to the pandemics, a cross-sectional study conducted in Brazilian capitals had already identified 13.8% of late maternal deaths among confirmed maternal deaths in 200232. In Recife (Pernambuco - PE), among 171 maternal deaths that occurred between 2006 and 2017, 20.5% were classified as late18.
In some publications, late maternal mortality is defined as the sum of deaths coded as O96 and O97 (obstetric sequelae occurring more than one year after delivery), which complicates the comparison of results, even though the frequency of deaths from obstetric sequelae is low and lower than that of late maternal deaths. In an ecological study conducted in seven countries in the Americas between 1999 and 2013, the highest proportion of late maternal deaths and deaths due to obstetric sequelae among total maternal deaths was observed in the United States (18.7%), followed by Cuba (11.5%), Argentina (approximately 6%), Brazil and Canada (approximately 5%), Mexico (3.6%), and Colombia (2.4%)33. The trend in late maternal mortality and deaths from obstetric sequelae in the Americas was upward: global mean APC (estimated using Poisson regression models) of 12.7%, and 9.7% for Brazil33.
In 2018, of the 935 maternal deaths recorded in the United States, 29.6% were classified as late maternal deaths (code O96), and the MMR and LMMR were 17.4 and 7.2 per 100,000 LB, respectively16. In comparison, in the same year, 21.8% of maternal deaths in the state of Rio de Janeiro were late, and the MMR and LMMR were 61.5 and 17.2 per 100,000 LB, respectively, corresponding to 3.5 and 2.4 times the values observed in the United States.
Pandemics contribute to the deterioration of healthcare systems and to excess mortality, even when infectious diseases are not explicitly listed among the causes of death6,7. Considering the national landscape of maternal mortality, it appears unlikely that the Sustainable Development Goal target of reducing the maternal mortality ratio to 30 per 100,000 live births by 2030 will be achieved34.
Surveillance and statistical reporting of late maternal deaths are complex processes35, and the challenge of minimizing or eliminating underreporting and misclassification remains2. Nonetheless, some progress has been made. In 2022, 54% of the 120 countries and territories included in the World Health Organization (WHO) maternal mortality statistics reported on late maternal mortality (ICD-10)2.
Classification errors of maternal and late maternal deaths may have occurred in this study due to limitations in the accuracy of certifying the underlying cause of death and the completion of field 37 (time of death in the pregnancy-puerperal cycle) on the DC. Additionally, changes in mortality trends estimated by joinpoint regression are constrained by the number of observations in the historical series, potentially limiting the robustness of analyses when pandemic biennia are excluded.
A notable strength of this study is the analysis of maternal mortality trends both including and excluding pandemic years. While Vega et al.14 recommend excluding epidemic years from trend analyses of maternal mortality, the methodological approach adopted in this study - joinpoint regression modeling - does not support such exclusion. On the contrary, this method allowed for the observation of how trends varied with the inclusion of pandemic biennia, whether jointly or separately. Thus, the dual analysis approach contributed to a more comprehensive understanding of the temporal behavior of maternal mortality. Furthermore, the high coverage of the SIM and Sinasc36, along with the increased proportion of investigations into deaths of women of childbearing age and maternal deaths, from 80.9% in 2010 to 93.7% in 2021 in the state37, enhanced the reliability of the data and the accuracy of estimates of maternal and late maternal mortality risks.
Late maternal deaths are not included in the calculation of MMR, the primary indicator in maternal mortality statistics; however, the increasing relevance of this component in the overall risk of maternal death must be considered. The WHO recommends calculating the late MMR separately, with the possibility of aggregating it with the MMR up to 42 days postpartum, provided that the composition of the indicator is clearly stated25. In the 11th revision of the ICD, maternal and late maternal deaths were grouped under the category of “comprehensive maternal deaths,” for which the corresponding indicator is the comprehensive or expanded MMR38. The systematic monitoring of this broader indicator should be incorporated into maternal mortality statistics. Additionally, follow-up during the late postpartum period is a key strategy for reducing preventable late maternal deaths19.
REFERENCES
-
1 World Health Organization. Maternal mortality [Internet]. Geneva: World Health Organization; 2023 [cited on Aug 7, 2023]. Available at: Available at: https://www.who.int/news-room/fact-sheets/detail/maternal-mortality
» https://www.who.int/news-room/fact-sheets/detail/maternal-mortality -
2 World Health Organization. Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division [Internet]. Geneva: World Health Organization; 2023 [cited on Aug 7, 2023]. Available at: Available at: https://www.who.int/publications/i/item/9789240068759
» https://www.who.int/publications/i/item/9789240068759 -
3 World Health Organization. Maternal mortality ratio (per 100 000 live births) [Internet]. Geneva: World Health Organization; 2023 [cited on Aug 7, 2023]. Available at: Available at: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/maternal-mortality-ratio-(per-100-000-live-births)
» https://www.who.int/data/gho/data/indicators/indicator-details/GHO/maternal-mortality-ratio-(per-100-000-live-births) -
4 Szwarcwald CL, Escalante JJC, Rabello Neto DL, Souza Junior PRB, Victora CG. Estimação da razão de mortalidade materna no Brasil, 2008-2011. Cad Saúde Pública 2014; 30 Suppl 1: S71-83. https://doi.org/10.1590/0102-311X00125313
» https://doi.org/https://doi.org/10.1590/0102-311X00125313 -
5 Mendonça IM, Silva JBF, Conceição JFF, Fonseca SC, Boschi-Pinto C. Tendência da mortalidade materna no Estado do Rio de Janeiro, Brasil, entre 2006 e 2018, segundo a classificação CID-MM. Cad Saúde Pública 2022; 38(3): e00195821. https://doi.org/10.1590/0102-311X00195821
» https://doi.org/https://doi.org/10.1590/0102-311X00195821 -
6 Souza ASR, Amorim MMR. Maternal mortality by COVID-19 in Brazil. Rev Bras Saúde Mater Infant. 2021; 21 (Suppl 1): S257-S261. https://doi.org/10.1590/1806-9304202100S100014
» https://doi.org/https://doi.org/10.1590/1806-9304202100S100014 -
7 Orellana J, Jacques N, Leventhal DGP, Marrero L, Morón-Duarte LS. Excess maternal mortality in Brazil: regional inequalities and trajectories during the COVID-19 epidemic. PLoS One 2022; 17(10): e0275333. https://doi.org/10.1371/journal.pone.0275333
» https://doi.org/https://doi.org/10.1371/journal.pone.0275333 -
8 Centro de Estudos Estratégicos da Fiocruz Antonio Ivo de Carvalho. Combate à epidemia de H1N1: um histórico de sucesso [Internet]. FIOCRUZ; 2021 [cited on Jun 07, 2024] Available at Available at https://cee.fiocruz.br/?q=node/1314#:~:text=O%20Brasil%20registrou%20quase%2060.000,s%C3%A3o%20produzidas%20pelo%20Instituto%20Butantan
» https://cee.fiocruz.br/?q=node/1314#:~:text=O%20Brasil%20registrou%20quase%2060.000,s%C3%A3o%20produzidas%20pelo%20Instituto%20Butantan -
9 Yokota RTC, Skalinski LM, Igansi CN, Souza LRO, Iser BPM, Reis PO, et al. Risk factors for death from pandemic (H1N1) 2009, southern Brazil. Emerg Infect Dis 2011; 17(8): 1467-71. https://doi.org/10.3201/eid1708.101233
» https://doi.org/https://doi.org/10.3201/eid1708.101233 - 10 Pastore APW, Prates C, Gutierrez LLP. Implicações da influenza A/H1N1 no período gestacional. Sci Med 2012; 22(1): 53-8.
-
11 Takemoto ML, Menezes MO, Andreucci CB, Nakamura-Pereira M, Amorim MM, Katz L et al. The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting. Int J Gynecol Obstet. 2020; 151: 154-6. https://doi.org/10.1002/ijgo.13300
» https://doi.org/https://doi.org/10.1002/ijgo.13300 - 12 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Análise de Situação de Saúde e Vigilância de Doenças não Transmissíveis. Orientações sobre novos códigos de emergência para as causas de morte relacionadas a condições que ocorrem no contexto da covid-19. Brasília: Ministério da Saúde; 2022.
-
13 Brendolim M, Fuller T, Wakimoto M, Rangel L, Rodrigues GM, Rohloff RD, et al. Severe maternal morbidity and mortality during the COVID-19 pandemic: a cohort study in Rio de Janeiro. IJID Reg 2023; 6: 1-6. https://doi.org/10.1016/j.ijregi.2022.11.004
» https://doi.org/https://doi.org/10.1016/j.ijregi.2022.11.004 -
14 Vega CEP, Santos JLO, Marcus PAF, Castro Filho JM, Terra CM. O impacto da pandemia por influenza A (H1N1) na mortalidade materna do Município de São Paulo 2009 [Internet]. 2009 [cited on May 03, 2024]. Available at: Available at: https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/arquivos/mulher/Mortalidade_Materna_por_H1N1.pdf
» https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/arquivos/mulher/Mortalidade_Materna_por_H1N1.pdf -
15 Gissler M, Kauppila R, Mefiläinen J, Toukomaa H, Hemmink E. Pregnancy-associated deaths in Finland 1987-1994 - definition problems and benefits of record linkage. Acta Obstet Gynecol Scand 1997; 76(7): 651-7. https://doi.org/10.3109/00016349709024605
» https://doi.org/https://doi.org/10.3109/00016349709024605 - 16 Hoyert DL. Maternal mortality and related concepts. Vital Health Stat 3 2007; (33): 1-13. PMID: 17460868.
-
17 Vega CEP, Soares VMN, Nasr AMLF. Mortalidade materna tardia: comparação de dois comitês de mortalidade materna no Brasil. Cad Saúde Pública 2017; 33(3): e00197315. https://doi.org/10.1590/0102-311X00197315
» https://doi.org/https://doi.org/10.1590/0102-311X00197315 -
18 Carvalho PI, Vidal SA, Figueirôa BQ, Vanderlei LCM, Oliveira CM, Pereira CCB, et al. Maternal mortality committee and death surveillance in Recife in improving information: ex-ante and ex-post evaluation. Rev Bras Saúde Mater Infant 2023; 23: e20220254. https://doi.org/10.1590/1806-9304202300000254-en
» https://doi.org/https://doi.org/10.1590/1806-9304202300000254-en -
19 Borgonove KCA, Lansky S, Soares VMN, Matozinhos FP, Martins EF, Silva RAR, et al. Análise de série temporal: tendência da mortalidade materna tardia no Brasil, 2010-2019. Cad Saúde Pública 2024; 40(7): e00168223. https://doi.org/10.1590/0102-311XPT168223
» https://doi.org/https://doi.org/10.1590/0102-311XPT168223 -
20 Sliwa K, Anthony J. Late maternal deaths: a neglected responsibility. Lancet 2006; 387(10033): 2072-3. https://doi.org/10.1016/S0140-6736(16)30391-9
» https://doi.org/https://doi.org/10.1016/S0140-6736(16)30391-9 - 21 Organização Mundial da Saúde. CID-10 Classificação Estatística Internacional de Doenças e Problemas Relacionados à Saúde. 10a revisão. São Paulo EDUSP; 1995.
-
22 National Cancer Institute. Division of Cancer Control & Population Sciences. Surveillance Research Program. Joinpoint [Internet]. [cited on Feb 20, 2025]. Available at: Available at: https://surveillance.cancer.gov/help/joinpoint/
» https://surveillance.cancer.gov/help/joinpoint/ -
23 Kim HJ, Chen HS, Byrne J, Wheeler B, Feuer EJ. Twenty years since Joinpoint 1.0: two major enhancements, their justification, and impact. Stat Med 2022; 41(16): 3102-30. https://doi.org/10.1002/sim.9407
» https://doi.org/https://doi.org/10.1002/sim.9407 -
24 Oliveira IVG, Maranhão TA, Frota MMC, Araujo TKA, Torres SRF, Rocha MIF, et al. Mortalidade materna no Brasil: análise de tendências temporais e agrupamentos espaciais. Ciênc Saúde Coletiva 2024; 29(10): e05012023. https://doi.org/10.1590/1413-812320242910.05012023
» https://doi.org/https://doi.org/10.1590/1413-812320242910.05012023 -
25 Critto ME, Enriquez Y, Bravo M, Quevedo LJ, Weinberg R, Etchegaray A, et al. Impact of emerging virus pandemics on cause-specific maternal mortality time series: a population-based natural experiment using national vital statistics, Argentina 1980-2017. Lancet Reg Health Am 2021; 6: 100116. https://doi.org/10.1016/j. lana.2021.100116
» https://doi.org/https://doi.org/10.1016/j. lana.2021.100116 -
26 Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr 2021; 175(8): 817-26. https://doi.org/10.1001/jamapediatrics.2021.1050
» https://doi.org/https://doi.org/10.1001/jamapediatrics.2021.1050 - 27 Kochanek KD, Murphy SL, Xu J, Arias E. Deaths: final data for 2020. Natl Vital Stat Rep 2023; 72(10): 1-92. PMID: 37748091.
-
28 Marteleto LJ, Sereno LGF, Coutinho RZ, Dondero M, Alves SV, Lloyd R, et al. Fertility trends during successive novel infectious disease outbreaks: Zika and COVID-19 in Brazil. Cad Saude Pública 2022; 38(4): EN230621 https://doi.org/10.1590/0102-311XEN230621
» https://doi.org/https://doi.org/10.1590/0102-311XEN230621 - 29 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Análise de Situação de Saúde. Mortalidade materna no Brasil: principais causas de morte e tendências temporais no período de 1990 a 2010. In: Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Análise de Situação de Saúde. Saúde Brasil 2011: uma análise da situação de saúde e a vigilância da saúde da mulher. Brasília: Ministério da Saúde; 2012. p. 345-58.
-
30 Scheler CA, Discacciati MG, Vale DB, Lajos GJ, Surita FG, Teixeira JC. Maternal deaths from COVID-19 in Brazil: increase during the second wave of the pandemic. Rev Bras Ginecol Obstet 2022; 44(6): 567-72. https://doi.org/10.1055/s-0042-1748975
» https://doi.org/https://doi.org/10.1055/s-0042-1748975 - 31 Ardila-Pereira L, Melendres-Vidal MO. COVID-19 en la mortalidad materna, perinatal y neonatal de cuatro localidades de Bogotá. Estudio descriptivo. Rev Esp Salud Pública 2023; 97: e202304034.
-
32 Laurenti R, Mello-Jorge MHP, Gotlieb SLD. A mortalidade materna nas capitais brasileiras: algumas características e estimativa de um fator de ajuste. Rev Bras Epidemiol 2004; 7(4): 449-60. https://doi.org/10.1590/S1415-790X2004000400008
» https://doi.org/https://doi.org/10.1590/S1415-790X2004000400008 -
33 Cosio FG, Jiwani SS, Sanhueza A, Soliz PN, Becerra-Posada F, Espinal MA. Late maternal deaths and deaths from sequelae of obstetric causes in the Americas from 1999 to 2013: a trend analysis. PLoS One 2016; 11(9): e0160642. https://doi.org/10.1371/journal.pone.0160642
» https://doi.org/https://doi.org/10.1371/journal.pone.0160642 -
34 Machado DB, Pescarini JM, Ramos D, Teixeira R, Lozano R, Pereira VOM, et al. Monitoring the progress of health-related sustainable development goals (SDGs) in Brazilian states using the Global Burden of Disease indicators. Popul Health Metr 2020; 18(Suppl 1): 7. https://doi.org/10.1186/s12963-020-00207-2
» https://doi.org/https://doi.org/10.1186/s12963-020-00207-2 -
35 GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388(10053): 1775-812. https://doi.org/10.1016/S0140-6736(16)31470-2
» https://doi.org/https://doi.org/10.1016/S0140-6736(16)31470-2 - 36 Laurenti R, Mello-Jorge MHP. Informação em saúde: o papel do médico. São Paulo: Conselho Regional de Medicina do estado de São Paulo; 2017.
-
37 Governo do Estado do Rio de Janeiro. Secretaria de Saúde. Informação SUS. Dados SUS. Estatísticas vitais - óbitos e nascimentos [Internet]. [cited on Apr 21, 2024]. Available at: Available at: https://www.saude.rj.gov.br/informacao-sus/dados-sus/2020/11/estatisticas-vitais-obitos-e-nascimentos
» https://www.saude.rj.gov.br/informacao-sus/dados-sus/2020/11/estatisticas-vitais-obitos-e-nascimentos -
38 World Health Organization. ICD-11 International Classification of Diseases for Mortality and Morbidity Statistics. Eleventh Revision [Internet]. 2022 [cited on May 22, 2023]. Available at: Available at: https://icdcdn.who.int/icd11referenceguide/en/html/index.html
» https://icdcdn.who.int/icd11referenceguide/en/html/index.html
-
HOW TO CITE THIS ARTICLE:
Bellizzi ALM, Cascão AM, Brito AS, Fonseca SC, Kale PL. Maternal and late mortality trends, emphasizing the H1N1 and COVID-19 pandemics, in the state of Rio de Janeiro, Brazil, from 2009 to 2021. Rev Bras Epidemiol. 2025; 28: e250037. https://doi.org/10.1590/1980-549720250037
-
FUNDING:
none.
Edited by
-
ASSOCIATED EDITOR:
Carmen Ildes Rodrigues Fróes Asmus. http://orcid.org/0000-0002-9864-6656
-
SCIENTIFIC EDITOR:
Cassia Maria Buchalla. http://orcid.org/0000-0001-5169-5533



MMR: maternal mortality ratio.Source: Mortality Information System and Live Births Systems.
LMMR: late maternal mortality ratio.Source: Mortality Information System and Live Births System.